Elosulfase alfa
id:
elosulfase-alfa-323-2844285
title:
Elosulfase alfa
text:
Elosulfase alfa, sold under the brand name Vimizim, is a medication used for the treatment of Morquio syndrome which is caused by a deficiency in the enzyme N-acetylgalactosamine-6-sulfatase. Elosulfase alfa is a synthetic version of this enzyme. Elosulfase alfa was developed by BioMarin Pharmaceutical Inc. and approved for use in the US by the Food and Drug Administration in 2014. Elosulfase alfa is used in enzyme replacement therapy; a 2014 study confirmed it was effective on young patients wi
brand slug:
wiki
category slug:
encyclopedia
description:
Pharmaceutical drug
original url:
https://en.wikipedia.org/wiki/Elosulfase_alfa
date created:
date modified:
2024-03-08T15:11:12Z
main entity:
{"identifier":"Q21011232","url":"https://www.wikidata.org/entity/Q21011232"}
image:
fields total:
13
integrity:
14